Orchard Group, inclusive of Orchard and Alfie, has emerged as the most decorated entity at the 2024 PRIME Awards. This year, the group bagged three awards, bringing their total to an impressive 10 over the past five years. The awards won by Orchard Group at this year's PRIME Awards include Excellence in Education for COPD Fairflow with Boehringer Ingelheim, Creativity in Communication – HCP for Long Story Short with Johnson & Johnson, and Marketing Campaign of the Year for the Anapen ‘Anaphylaxis is Unpredictable’ Campaign with Arrotex.

Orchard Group was also a finalist for Launch of the Year for BeiGene’s Brukinsa CLL launch and Sustained Excellence for Know Shingles with GSK. The group was shortlisted for Digital Agency of the Year at the 2024 AdNews Australia Agency of the Year Awards.

The PRIME Awards celebrate excellence within the healthcare communications and the Australian pharmaceutical and life sciences industry.

Wai Kwok, CEO of Orchard Group, said, "I'm very proud that the Orchard Group has proven to be the most awarded Australian group at PRIME for the results it has achieved for its clients over the last five years. The pharma landscape has changed dramatically in the last year alone.

"It’s no longer enough to just have a great creative visual; You also need to harness technology and MedEd to deliver more innovative, personal and credible connected experiences that drive measurable ROI and behaviour change. This is the future and Orchard Group’s diverse capabilities across strategy, creative, medical education and technology make us best equipped to meet evolving client, clinician and patient needs– our consistent track record and recognition at PRIME Awards across best product launch, patient support, use of data, MedEd as well as creativity over the last five years demonstrates this."